Pine Labs Limited has submitted its Monitoring Agency Report for the quarter ended September 30, 2026. This report, issued by CARE Ratings Limited, details the utilization of proceeds from the company’s Initial Public Issue (IPO). The findings have been reviewed by the Board of Directors and the Audit Committee, confirming adherence to disclosure requirements.
Monitoring Agency Report Submitted for Q2 FY27
Pine Labs Limited has officially filed its Monitoring Agency Report for the fiscal quarter ending September 30, 2026. This report is a crucial component of regulatory compliance, detailing the use of funds raised during the company’s Initial Public Offering (IPO).
Key Findings from the Report
The report, prepared by the appointed Monitoring Agency, CARE Ratings Limited, provides an objective view of the utilization of IPO proceeds in relation to the company’s stated objectives. According to the document, there were no deviations from the stated objects of the issue during this period.
The utilization of funds is presented in detail, covering various objects such as repayment of borrowings, investments in subsidiaries, IT assets, cloud infrastructure, and procurement of digital check-out points. The report confirms that all utilization aligns with the disclosures made in the Offer Document.
Board Review and Public Availability
Pine Labs Limited has stated that the Monitoring Agency Report has been placed before and considered by its Board of Directors and Audit Committee during their meetings held on October 29, 2026. The information contained within the report is also made available on the company’s investor relations website at https://www.pinelabs.com/investor-relations.
Source: BSE
